Key statistics
On Friday, Hercules Capital Inc (HCXY:NYQ) closed at 25.26, -1.78% below its 52-week high of 25.71, set on Nov 05, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 25.26 |
|---|---|
| High | 25.27 |
| Low | 25.18 |
| Bid | 25.16 |
| Offer | -- |
| Previous close | 25.29 |
| Average volume | 4.29k |
|---|---|
| Shares outstanding | -- |
| Free float | -- |
| P/E (TTM) | -- |
| Market cap | -- |
| EPS (TTM) | -- |
| Annual div (ADY) | 1.56 USD |
|---|---|
| Annual div yield (ADY) | 6.19% |
| Div ex-date | Jan 15 2026 |
| Div pay-date | Jan 30 2026 |
Data delayed at least 15 minutes, as of Feb 13 2026 18:54 GMT.
More ▼
Press releases
- Hercules Capital Reports Fourth Quarter and Full-Year 2025 Financial Results
- Hercules Capital Closes Institutional Notes Offering of $300.0 Million 5.350% Unsecured Notes due 2029
- Hercules Capital Announces New Supplemental Cash Distribution of $0.28 per Share
- Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Fourth Quarter 2025
- Hercules Capital Prices Institutional Notes Offering of $300.0 Million 5.350% Notes due 2029
- Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2025 Financial Results and Conference Call
- Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of MOLBREEVI*
- enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.
- Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD
More ▼
